Literature DB >> 14714572

HIV type 1 diversity in northeastern Romania in 200-2001 based on phylogenic analysis of pol sequences from patient failing antiretroviral therapy.

Cristian Apetrei1, Diane Descamps, Gilles Collin, David L Robertson, Ivona Pandrea, Petru Groza, Liviu Prisecariu, Irina Teodorescu, Vasile Luca, Françoise Brun-Vézinet.   

Abstract

Protease and the first half of reverse transcriptase from 71 Romanian patients failing highly active antiretroviral therapy (HAART) have been sequenced and phylogenetically analyzed. These analyses show that 70 patients were infected with subtype F1 and one with subtype C. The pattern of drug resistance mutations in subtype F1-infected patients failing HAART is similar to that described for subtype B strains. These results show that the diversity pattern of HIV type 1 infection in Romania has remained steady over a decade, with subtype F1 remaining the predominant viral form. The circulation of subtype F1 in Romania has the potential to be a source of this HIV-1 subtype in Europe..

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14714572     DOI: 10.1089/088922203771881266

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  3 in total

1.  Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria.

Authors:  Barbara Falkensammer; Martin Doerler; Harald H Kessler; Elisabeth Puchhammer-Stoeckl; Walter Parson; Christina Duftner; Manfred P Dierich; Heribert Stoiber
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

2.  HIV Genetic Diversity and Drug Resistance.

Authors:  André F Santos; Marcelo A Soares
Journal:  Viruses       Date:  2010-02-02       Impact factor: 5.818

3.  Near full-length genome analysis of low prevalent human immunodeficiency virus type 1 subclade F1 in São Paulo, Brazil.

Authors:  Sabri Saeed Sanabani; Evelyn Regina de Souza Pastena; Walter Kleine Neto; Claudia C Barreto; Kelly T Ferrari; Erika M N Kalmar; Suzete Ferreira; Ester Cerdeira Sabino
Journal:  Virol J       Date:  2009-06-16       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.